Occupational and industry prevalence of new long‐term symptoms within American Red Cross blood donors with and without history of SARS‐CoV‐2 infection
American Journal of Industrial Medicine · 2024
DOI: 10.1002/ajim.23670 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Industrial Medicine, 2024. Verfasst von Deja L Edwards und 8 weiteren Autor:innen. Beteiligte Einrichtung: Eagle Global Scientific, Huntsville, Alabama, USA. Hauptthemen laut MEDLINE: Blood Donors, COVID-19, Red Cross, SARS-CoV-2. Die Arbeit nennt 30 Literaturangaben. Gefördert von: CDC HHS, American Red Cross, Centers for Disease Control and Prevention.
Abstract (Originalsprache)
Purpose
Limited information is known about the burden of Long COVID by occupation and industry. This study compares the occurrence of self‐reported new long‐term symptoms lasting 4 weeks or longer among blood donors with and without prior SARS‐CoV‐2 infection by occupation and industry.
Methods
The American Red Cross invited blood donors 18 years and older who donated during May 4–December 31, 2021 to participate in online surveys. New long‐term symptoms lasting 4 weeks or longer were assessed by self‐reported occurrence of any of 35 symptoms since March 2020. SARS‐CoV‐2 infection status was determined by serological testing and self‐report. We describe the prevalence of new long‐term symptoms by SARS‐CoV‐2 infection status. We calculate the difference in reported new long‐term symptoms by SARS‐CoV‐2 infection status within occupation and industry categories.
Results
Data were collected from 27,907 employed adults – 9763 were previously infected and 18,234 were never infected with SARS‐CoV‐2. New long‐term symptoms were more prevalent among those previously infected compared to the never‐infected respondents (45% vs 24%, p < 0.05). Among all respondents, new long‐term symptoms by occupation ranged from 26% (installation, maintenance, and repair) to 41% (healthcare support) and by industry ranged from 26% (mining) to 55% (accommodation and food services). New long‐term neurological and other symptoms were commonly reported by those previously infected with SARS‐CoV‐2.
Discussion
New long‐term symptoms are more prevalent among certain occupation and industry groups, which likely reflects differential exposure to SARS‐CoV‐2. These findings highlight potential need for workplace accommodations in a variety of occupational settings to address new long‐term symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Eagle Global Scientific, Huntsville, Alabama, USA.
- Coronavirus & Other Respiratory Viruses Division (CORVD) National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
- Division of Field Studies and Engineering, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, Ohio, USA.
- American Red Cross, Washington, District of Columbia, USA.
ORCID-Profile: Deja L Edwards, Dallas S Shi
Förderung
- CDC HHS
- American Red Cross
- Centers for Disease Control and Prevention
Zitieren
APA
Edwards, D. L., Shah, M. M., Shi, D. S., Ford, N. D., Rinsky, J. L., Jones, J. M., Spencer, B., Haynes, J., & Saydah, S. H. (2024). Occupational and industry prevalence of new long‐term symptoms within American Red Cross blood donors with and without history of SARS‐CoV‐2 infection. American Journal of Industrial Medicine. https://doi.org/10.1002/ajim.23670
Vancouver
Edwards DL, Shah MM, Shi DS, Ford ND, Rinsky JL, Jones JM, et al. Occupational and industry prevalence of new long‐term symptoms within American Red Cross blood donors with and without history of SARS‐CoV‐2 infection. American Journal of Industrial Medicine. 2024. doi:10.1002/ajim.23670
BibTeX
@article{Edwards2024,
author = {Edwards, Deja L and Shah, Melisa M and Shi, Dallas S and Ford, Nicole D and Rinsky, Jessica L and Jones, Jefferson M and Spencer, Bryan and Haynes, James and Saydah, Sharon H},
title = {Occupational and industry prevalence of new long‐term symptoms within American Red Cross blood donors with and without history of SARS‐CoV‐2 infection},
journal = {American Journal of Industrial Medicine},
year = {2024},
doi = {10.1002/ajim.23670}
}
EUVIMED